19:41 , Jun 2, 2017 |  BioCentury  |  Product Development

Ears wide open

Based on unmet need alone, hearing loss should have been every bit as attractive to investors and drug developers as ophthalmic diseases, which entered a renaissance in the mid-2000s resulting in a multibillion-dollar market for...
07:00 , May 23, 2011 |  BioCentury  |  Finance

Euro IPOs

Euro IPOs French cancer diagnostic play Median Technologies Inc. and Swedish dermatology company Moberg Derma AB completed IPOs last week, while Dutch molecular diagnostic company Agendia B.V. added itself to the queue. Median raised €10 million ($14.1...
07:00 , Mar 15, 2010 |  BC Week In Review  |  Company News

Genticel board of directors update

Genticel S.A., Labege, France   Business: Cancer, Infectious   Appointed: Alain Munoz, representative of AGF Private Equity   ...
07:00 , Mar 15, 2010 |  BC Week In Review  |  Financial News

Genticel completes venture financing

Genticel S.A., Labege, France   Business: Cancer, Infectious   Date completed: 3/9/10   Type: Venture financing   Raised: €13.1 million ($17.8 million)   Investors: AGF Private Equity; Institut Regional de Developpement Industriel; Amundi Private Equity Funds; InnoBio Fund; Edmond de...
02:10 , Mar 10, 2010 |  BC Extra  |  Financial News

BT Pharma raises EUR 13.1 million

BT Pharma S.A. (Labege, France) raised EUR 13.1 million ($17.8 million) in a series B round led by new investor AGF. Additional new investors Institut Regional de Developpement Industriel; Amundi Private Equity Funds; and InnoBio...
08:00 , Jan 11, 2010 |  BC Week In Review  |  Financial News

Adocia completes venture financing

Adocia S.A.S., Lyon, France   Business: Musculoskeletal, Dermatology   Date completed: 1/5/10   Type: Venture financing   Raised: €14 million ($20.1 million)   Investors: InnoBio Fund; SHAM; AGF; Societe Generale; BioAm; Viveris Management; individual investors   ...
03:17 , Jan 7, 2010 |  BC Extra  |  Financial News

Adocia raises EUR 14 million

Adocia S.A.S. (Lyon, France) raised EUR 14 million ($20.1 million) in a series B round led by new investor InnoBio Fund, a venture fund managed by CDC Enterprises and sponsored by the French government's Fonds...
08:00 , Dec 14, 2009 |  BioCentury  |  Finance

Ebb & Flow

Investors in oncology company Gloucester Pharmaceuticals Inc. are looking at a 3.5X-6.5X return on an acquisition by Celgene Corp. (NASDAQ: CELG), making it a model for how to execute in-licensing and keep costs under control. Since...
08:00 , Dec 7, 2009 |  BC Week In Review  |  Financial News

BMD completes venture financing

Biomedical Diagnostics S.A., Marne-la-Vallee, France   Business: Diagnostic   Date completed: 12/1/09   Type: Venture financing   Raised: €3 million ($4.5 million)   Investors: Truffle Capital; AGF Private Equity   ...
07:00 , Oct 19, 2009 |  BC Week In Review  |  Financial News

Cellectis proposes private placement

Cellectis S.A. (Euronext:ALCLS), Romainville, France   Business: Gene/Cell therapy, Genomics   Date announced: 10/14/09   Type: Private placement   To be raised: About € 20 million ($29.4 million)   Shares: 1.9 million   Price prior: €13.84   Placement agent: Natixis   Shares outstanding...